Dr. Royal Son Park, MD

Dr. Park practices at Genesis Healthcare Partners in Torrance, California.

Dr. Park's NPI, 1336192301, was assigned on May 18, 2006. Dr. Park graduated from New York University School of Medicine in 1996. Dr. Park holds California license A79808.

Dr. Park's primary practice is Genesis Healthcare Partners, at 23600 Telo Ave, Torrance, CA 90505 in Los Angeles County. The practice phone is (760) 436-4558.

Dr. Park's primary practice is Genesis Healthcare Partners in Torrance, California. Dr. Park is also affiliated with Torrance Memorial Medical Center. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Dr. Park to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Park practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Park's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Park is board certified in urology by the American Board of Urology. Dr. Park is licensed in California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Park treats.

CMS data shows 3,359 Medicare services from Dr. Park across 18 procedure codes in 2024, for 487 Medicare patients. Medicare paid $182,981 for them.

CMS counts 487 Medicare patients who saw Dr. Park in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Park's median patient age at 71, with 23% women.

In 2024, Dr. Park wrote 2,581 Medicare Part D claims for 632 patients. 90% of them were for generic drugs. CMS names the drug for 2,466 of them, across 22 drugs with 11 or more claims each, at $291,599 in total drug cost. In 2023, CMS named 2,229 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Park for performance year 2024, reported as part of a group. Dr. Park accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Park as offering telehealth.

CMS Open Payments shows 604 general payments to Dr. Park from 62 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Astellas Pharma US Inc paid the most, $1,713.

Dr. Park graduated from New York University School of Medicine in 1996.

Dr. Park is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.